Mayne Pharma is a pharmaceutical company that focuses on developing, manufacturing, and marketing generic and branded pharmaceutical products. With a global presence, Mayne Pharma serves markets primarily in the United States, Australia, and other regions.
Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on commercializing branded and generic pharmaceuticals.
We have a 40-year track record of innovation and success developing new oral drug delivery systems and these technologies have been successfully commercialized in numerous products that continue to be marketed around the world.
Key Aspects of Mayne Pharma:
- Product Portfolio:
- Generic Pharmaceuticals: Mayne Pharma offers a broad range of generic drugs across various therapeutic areas, including dermatology, cardiology, women’s health, and more.
- Branded Pharmaceuticals: The company also markets branded medications, focusing on niche therapeutic segments where they can offer significant clinical benefits.
- Specialty Products: They provide specialty pharmaceuticals, which often involve complex formulations or delivery systems.
- Research and Development (R&D):
- Mayne Pharma invests heavily in R&D to develop new and improved pharmaceutical products. Their R&D efforts focus on both the development of new chemical entities and the enhancement of existing medications.
- The company has facilities dedicated to formulation development, analytical testing, and clinical trials to support their pipeline of new products.
- Manufacturing Capabilities:
- State-of-the-Art Facilities: Mayne Pharma operates advanced manufacturing facilities in the United States and Australia. These facilities are equipped to produce a wide variety of dosage forms, including tablets, capsules, injectables, and topical products.
- Quality Assurance: The company adheres to stringent quality control standards to ensure that their products meet regulatory requirements and are safe for patient use.
- Market Presence:
- United States: The US market is a significant focus for Mayne Pharma, where they distribute a large portion of their generic and branded products.
- Australia and International Markets: While they have a strong presence in Australia, Mayne Pharma also markets their products in other international regions.
- Strategic Partnerships:
- Mayne Pharma collaborates with other pharmaceutical companies and research institutions to enhance their product offerings and expand their market reach.
- These partnerships often involve co-development, licensing, and distribution agreements.
- Compliance and Certifications:
- The company complies with all relevant regulatory standards, including those set by the FDA in the United States and other international regulatory bodies.
- Mayne Pharma holds various certifications that attest to their commitment to quality and safety.
Vision and Mission:
Mayne Pharma’s mission is to improve health outcomes for patients by providing high-quality, affordable pharmaceuticals. They aim to be a leading specialty pharmaceutical company through innovation, operational excellence, and strategic growth.
Contact Information:
For more details about Mayne Pharma, their products, services, or business inquiries, you can visit their official website or contact them directly:
- Website: Mayne Pharma
- Phone: +61 8 8209 2666 (Australia) | +1 800 272 5525 (USA)
- Headquarters: 1538 Main North Road, Salisbury South, SA 5106, Australia
This overview provides a comprehensive look at Mayne Pharma, highlighting their product offerings, R&D efforts, manufacturing capabilities, market presence, and commitment to quality and innovation in the pharmaceutical industry.
Product List:
ANNOVERA® Vaginal Ring
(segesterone acetate/ethinyl estradiol)
BIJUVA® (0.5 mg estradiol/100 mg progesterone) Capsule NEW
(estradiol/progesterone)
BIJUVA® (1 mg estradiol/100 mg progesterone) Capsule
(estradiol/progesterone)
DORYX® Delayed-Release Tablets
(doxycycline hyclate)
DORYX® MPC Delayed-Release Tablets
(doxycycline hyclate)
DOXYCYCLINE HYCLATE DR Tablets
(doxycycline hyclate, delayed-release)
FABIOR® Foam
(tazarotene)
IMVEXXY® (estradiol 10 mcg) Vaginal Insert
(estradiol)
IMVEXXY® (estradiol 4 mcg) Vaginal Insert
(estradiol)
LEXETTE® Foam
(halobetasol propionate)
NEXTSTELLIS® Tablets
(drospirenone/estetrol)
ORACEA® AG Capsules
(doxycycline) 40mg capsule (30mg immediate release/10mg delayed release).
RHOFADE® NEW
(oxymetazoline hydrochloride, 1%)
SOLTAMOX® Oral Solution
(tamoxifen citrate)
SORILUX® Foam
(calcipotriene)
TOLSURA® Capsules
SUBA®-itraconazole
VITAMEDMD® ONE RX Multivitamin Capsule
Softgel capsules as prenatal multivitamins with DHA & quatrefolic, glucose, lactose, sugar free
VITAPEARL® Prenatal Multivitamin Capsule
Softgel capsules as prenatal multivitamins with DHA, glucose. lactose, sugar free
VITATRUE® Prenatal Multivitamin Tablet With DHA Capsules
Tablets as prenatal multivitamins with DHA softgel capsules, glucose, lactose, sugar free
WYNZORA® NEW
(calcipotriene and betamethasone dipropionate) Cream, 0.005%/0.064%